Document is current
Any future updates will be listed below
-
Authors
Park, Changhee https://orcid.org/0000-0002-7125-9795
Lee, Ho Sup
Kang, Ka-Won https://orcid.org/0000-0003-1462-0502
Lee, Won-Sik
Do, Young Rok
Kwak, Jae-Yong https://orcid.org/0000-0002-8070-4002
Shin, Ho-Jin
Kim, Sung-Yong
Yi, Jun Ho
Lim, Sung-Nam
Lee, Jeong-Ok
Yang, Deok-Hwan https://orcid.org/0000-0002-8167-8520
Jang, Hun
Choi, Byoungsan
Lim, Jiwoo
Sun, Choong Hyun
Byun, Ja Min https://orcid.org/0000-0003-1780-5553
Yoon, Sung-Soo https://orcid.org/0000-0003-2591-7459
Koh, Youngil https://orcid.org/0000-0002-4750-931X
-
Funding
Funding for this research was provided by:
AstraZeneca Korea (ESR-18-13701)
Celltrion Healthcare Co., Ltd Samyang Holdings
- License Information
-
More Information
Article History
Received: 12 September 2023
Accepted: 20 March 2024
First Online: 30 March 2024
Competing interests
: C.H.S. and Y.K. are founder and stockholder of GenomeOpinion Incorporation. J.L. is employee of GenomeOpinion Incorporation. H.J. and B.C. are employee of PROTEINA corporation. The other authors have no conflict of interest.
